BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27233218)

  • 1. Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
    Gully JC; Sergeyev VG; Bhootada Y; Mendez-Gomez H; Meyers CA; Zolotukhin S; Gorbatyuk MS; Gorbatyuk OS
    Neurosci Lett; 2016 Aug; 627():36-41. PubMed ID: 27233218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pedunculopontine cell loss and protein aggregation direct microglia activation in parkinsonian rats.
    Elson JL; Yates A; Pienaar IS
    Brain Struct Funct; 2016 May; 221(4):2319-41. PubMed ID: 25989851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
    Coune PG; Bensadoun JC; Aebischer P; Schneider BL
    J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.
    Acosta SA; Tajiri N; de la Pena I; Bastawrous M; Sanberg PR; Kaneko Y; Borlongan CV
    J Cell Physiol; 2015 May; 230(5):1024-32. PubMed ID: 25251017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.
    Caudal D; Alvarsson A; Björklund A; Svenningsson P
    Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
    Decressac M; Mattsson B; Lundblad M; Weikop P; Björklund A
    Neurobiol Dis; 2012 Mar; 45(3):939-53. PubMed ID: 22182688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with Trehalose Prevents Behavioral and Neurochemical Deficits Produced in an AAV α-Synuclein Rat Model of Parkinson's Disease.
    He Q; Koprich JB; Wang Y; Yu WB; Xiao BG; Brotchie JM; Wang J
    Mol Neurobiol; 2016 May; 53(4):2258-68. PubMed ID: 25972237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morpho-Functional Changes of Nigral Dopamine Neurons in an α-Synuclein Model of Parkinson's Disease.
    Ledonne A; Massaro Cenere M; Paldino E; D'Angelo V; D'Addario SL; Casadei N; Nobili A; Berretta N; Fusco FR; Ventura R; Sancesario G; Guatteo E; Mercuri NB
    Mov Disord; 2023 Feb; 38(2):256-266. PubMed ID: 36350188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease.
    Sugama S; Sekiyama K; Kodama T; Takamatsu Y; Takenouchi T; Hashimoto M; Bruno C; Kakinuma Y
    Brain Behav Immun; 2016 Jan; 51():39-46. PubMed ID: 26291405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.
    Hayashita-Kinoh H; Yamada M; Yokota T; Mizuno Y; Mochizuki H
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1088-95. PubMed ID: 16460685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating transcription factor-4 promotes neuronal death induced by Parkinson's disease neurotoxins and α-synuclein aggregates.
    Demmings MD; Tennyson EC; Petroff GN; Tarnowski-Garner HE; Cregan SP
    Cell Death Differ; 2021 May; 28(5):1627-1643. PubMed ID: 33277577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera A; Muñoz P; Steinbusch HWM; Segura-Aguilar J
    ACS Chem Neurosci; 2017 Apr; 8(4):702-711. PubMed ID: 28233992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct intranigral injection of dopaminochrome causes degeneration of dopamine neurons.
    Touchette JC; Breckenridge JM; Wilken GH; Macarthur H
    Neurosci Lett; 2016 Jan; 612():178-184. PubMed ID: 26704434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons.
    Salganik M; Sergeyev VG; Shinde V; Meyers CA; Gorbatyuk MS; Lin JH; Zolotukhin S; Gorbatyuk OS
    Neurobiol Aging; 2015 Jun; 36(6):2213-23. PubMed ID: 25863526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose regulated protein 78 diminishes α-synuclein neurotoxicity in a rat model of Parkinson disease.
    Gorbatyuk MS; Shabashvili A; Chen W; Meyers C; Sullivan LF; Salganik M; Lin JH; Lewin AS; Muzyczka N; Gorbatyuk OS
    Mol Ther; 2012 Jul; 20(7):1327-37. PubMed ID: 22434142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease.
    Badillo-Ramírez I; Saniger JM; Rivas-Arancibia S
    Neurochem Int; 2019 Oct; 129():104514. PubMed ID: 31369776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hTH-GFP reporter rat model for the study of Parkinson's disease.
    Iacovitti L; Wei X; Cai J; Kostuk EW; Lin R; Gorodinsky A; Roman P; Kusek G; Das SS; Dufour A; Martinez TN; Dave KD
    PLoS One; 2014; 9(12):e113151. PubMed ID: 25462571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation.
    Li Y; Liu W; Li L; Hölscher C
    Eur J Pharmacol; 2017 Feb; 797():162-172. PubMed ID: 27913104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.